Kindstar Globalgene Technology (Kindstar Globalgene Technology) EV-to-EBIT : 33.70 (As of Jun. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Kindstar Globalgene Technology's Enterprise Value is $241.7 Mil. Kindstar Globalgene Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $7.2 Mil. Therefore, Kindstar Globalgene Technology's EV-to-EBIT for today is 33.70.

The historical rank and industry rank for Kindstar Globalgene Technology's EV-to-EBIT or its related term are showing as below:

KDGTF' s EV-to-EBIT Range Over the Past 10 Years
Min: -11.01 Med: -3.78 Max: 2.03
Current: -7.54

During the past 6 years, the highest EV-to-EBIT of Kindstar Globalgene Technology was 2.03. The lowest was -11.01. And the median was -3.78.

KDGTF's EV-to-EBIT is ranked better than
98.97% of 97 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.17 vs KDGTF: -7.54

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Kindstar Globalgene Technology's Enterprise Value for the quarter that ended in Dec. 2023 was $0.0 Mil. Kindstar Globalgene Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $7.2 Mil. Kindstar Globalgene Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.

Kindstar Globalgene Technology EV-to-EBIT Historical Data

The historical data trend for Kindstar Globalgene Technology's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology EV-to-EBIT Chart

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-1.44

7.27

-5.72

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial					-1.44	-	7.27	-	-5.72

Competitive Comparison of Kindstar Globalgene Technology's EV-to-EBIT

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kindstar Globalgene Technology's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's EV-to-EBIT falls into.

Kindstar Globalgene Technology EV-to-EBIT Calculation

Kindstar Globalgene Technology's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	241.662	/	7.172
	=	33.70

Kindstar Globalgene Technology's current Enterprise Value is $241.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $7.2 Mil.

Kindstar Globalgene Technology (OTCPK:KDGTF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Kindstar Globalgene Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	7.172	/	0
	=	%

Kindstar Globalgene Technology's Enterprise Value for the quarter that ended in Dec. 2023 was $0.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $7.2 Mil.

Kindstar Globalgene Technology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (Kindstar Globalgene Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (OTCPK:KDGTF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

09960:Hong Kong

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (Kindstar Globalgene Technology) Headlines

No Headlines